Related Experiment Video

Updated: Aug 16, 2026

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
09:25

Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma

Published on: October 14, 2016

Rhabdomyosarcoma and other soft tissue sarcomas of childhood

A S Pappo1

  • 1Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101-0318, USA.

Current Opinion in Oncology
|July 1, 1995
PubMed

Insights

This review highlights advances in pediatric soft tissue sarcoma, including rhabdomyosarcoma. Risk-factor-based therapy improves cure rates, while genetic insights aid diagnosis and novel treatments.

Area of Science:

  • Pediatric Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Rhabdomyosarcoma and other pediatric soft tissue sarcomas are rare but aggressive cancers.
  • Current therapeutic strategies require refinement for improved patient outcomes.

Purpose of the Study:

  • To summarize recent literature on pediatric soft tissue sarcoma biology and therapy.
  • To highlight advances in diagnosis, staging, and treatment development.

Main Methods:

  • Literature review of the past year's publications.
  • Analysis of findings from the third Intergroup Rhabdomyosarcoma Study.
  • Review of recent genetic and molecular discoveries.

Main Results:

  • Therapy tailored to risk factors significantly improves cure rates for rhabdomyosarcoma.
  • Specific chromosomal translocations identified in tumor subtypes.
  • Genetic features of these tumors are being elucidated.

Conclusions:

  • Risk-stratified therapy is crucial for pediatric soft tissue sarcoma treatment.
  • Molecular insights offer potential for improved diagnostics and targeted therapies.
  • Understanding tumorigenesis mechanisms will drive novel treatment development.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...